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Abstract
Background:  Data provided by the social sciences as well as genetic research suggest that the 8-
10 million Roma (Gypsies) who live in Europe today are best described as a conglomerate of
genetically isolated founder populations. The relationship between the traditional social structure
observed by the Roma, where the Group is the primary unit, and the boundaries, demographic
history and biological relatedness of the diverse founder populations appears complex and has not
been addressed by population genetic studies.
Results:  Recent medical genetic research has identified a number of novel, or previously known
but rare conditions, caused by private founder mutations. A summary of the findings, provided in
this  review,  should  assist  diagnosis  and  counselling  in  affected  families,  and  promote  future
collaborative  research.  The  available  incomplete  epidemiological  data  suggest  a  non-random
distribution of disease-causing mutations among Romani groups.
Conclusion:  Although far from systematic, the published information indicates that medical
genetics has an important role to play in improving the health of this underprivileged and forgotten
people of Europe. Reported carrier rates for some Mendelian disorders are in the range of 5 -15%,
sufficient to justify newborn screening and early treatment, or community-based education and
carrier  testing  programs  for  disorders  where  no  therapy  is  currently  available.  To  be  most
productive,  future  studies  of  the  epidemiology  of  single  gene  disorders  should  take  social
organisation and cultural anthropology into consideration, thus allowing the targeting of public
health programs and contributing to the understanding of population structure and demographic
history of the Roma.
Introduction
The Roma (Gypsies) became one of the peoples of Eu-
rope around one thousand years ago, when they first ar-
rived in the Balkans [1,2]. The current size of the
European Romani population, around 8 million [2], is
equivalent to that of an average European country (Fig-
ure 1). While human rights and socio-economic issues
related to the Roma are increasingly becoming the focus
of political debate and media coverage throughout Eu-
rope, their poor health status [3–6] is rarely discussed
and still awaits the attention of the medical profession.
This review of genetic studies of the Roma was prompted
by two recent developments: (i) Studies conducted over
the last decade have resulted in the identification of a
number of novel single gene disorders and disease-caus-
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ing mutations. The accumulating data are already suffi-
cient to outline a pattern and draw conclusions about
public health policies and future research. (ii) The eco-
nomic and political changes in Eastern Europe and the
wars in former Yugoslavia have led to the west-bound
migration of large numbers of Roma [7,8], changing the
Figure 1
Romani population size in different European countries The collection of this type of data depends on declared ethnic
identity which, in the case of the Roma, can be affected by a number of political and social circumstances. The estimates in the
figure are the average of the numbers provided by different sources, such as census data, ministries of internal affairs and
human rights organizations [2].BMC Medical Genetics (2001) 2:5 http://www.biomedcentral.com/1471-2350/2/5
traditional demographic profile of Gypsy minorities
across Europe. A predictable consequence of this new di-
aspora is that medical practitioners in many countries
will encounter Romani patients with previously un-
known or very rare disorders. A summary of the available
information should facilitate diagnostic investigations
and counselling in these affected families and stimulate
international collaboration.
Materials and Methods
Literature searches were performed using the U.S.A Na-
tional Library of Medicine PubMed/MEDLINE databas-
es for the period 1960 to December 2000. Database
searches using the keyword "Gypsies" identified 297 ar-
ticles whilst the keyword "Gypsy" produced 573 articles.
The discrepancy is due mainly to the inclusion of articles
about the "gypsy retransposable element" and the "gypsy
moth". Searches using the terms "Roma", "Romani" and
"Romany" yielded results that were not relevant to the
topic (eg. Roma, the capital of Italy) or else incomplete.
The majority of the 297 articles dealt with issues beyond
the focus of this review, namely social problems related
to the health of the Roma (28.6%), or general medical
problems (29.6%). The remainder were reports on ge-
netic research, of which 41 studies (13.8%) were in the
field of clinical genetics, 44 (14.8%) were molecular stud-
ies of genetic disorders, and 39 (13.1%) covered popula-
tion genetic research. In the clinical and molecular
genetics fields, we have given preference to publications
which were not limited to single case descriptions, and
dealt with disorders with public health impact. Popula-
tion genetics papers were selected on the basis of the
compatibility of study design, specifically the analysis of
comparable polymorphic systems.
Complementary data on history, linguistics, cultural an-
thropology and demography were found through stand-
ard library and bibliographic searches, and included
publications recommended by consulting experts in
Romani studies (Drs. Elena Marushiakova and Vesselin
Popov from the Bulgarian Academy of Sciences and Dr.
Ian Hancock from the University of Texas at Austin).
The "Track Record" of Genetics
Genetic studies of the Roma have been conducted for
over 70 years, with thousands of individuals sampled
across Europe. During the years of the Third Reich, Gyp-
sies, together with Jews, attracted the special attention of
German geneticists [9]. A grant proposal signed by Nobel
prize winner Ferdinand Sauerbruch and funded by the
Deutsche Forschungsgemeinschaft designed the "genetic
and medical research" at the death camp in Auschhwitz
[9]. The Race Hygiene and Population Biology Research
Centre, established in 1936, organised thorough records
of Jewish and Romani pedigrees and provided "the sci-
entific basis" for the "final solution", the annihilation of
millions of Jews and Roma in the concentration camps of
Nazi-occupied Europe.
Post-war genetic research has been preoccupied with the
Indian origins of the Roma [10–16], pursuing the "Indi-
an connection" even in studies meant to focus on severe
genetic disorders [17]. Most studies have remained in the
realm of scientific exploration, away from the health
needs of the Roma. Many publications display judge-
mental and paternalistic attitudes, that would be consid-
ered unacceptable if used with regard to other
populations.
This historical "track record", the persisting practices of
discrimination and marginalisation [3–6], and the fact
that, unlike the Jews, the Finns and the French Canadi-
ans, the Roma are still the "object" of investigations con-
ducted by outsiders, are all likely to impact on the
attitudes of the Roma towards genetics. Building up the
trust and collaboration necessary for both public health
programs and research, should become a goal of the
health care systems of Europe.
Population Genetics
Population genetic studies have used mostly "classical"
polymorphisms to investigate Romani individuals from
different European counties and address three main
questions: (i) similarity between Roma and Indians; (ii)
relatedness to European populations; (iii) affinities be-
tween Romani populations from different countries [10–
24]. Single locus comparisons have resulted in contro-
versy, with some pointing to close genetic affinity be-
tween Roma and Indians, and others indicating that the
Roma are indistinguishable from Europeans. Heteroge-
neity between countries has become apparent and has
led to the conclusion that the European Roma are com-
posed of two different populations, characterised respec-
tively by a high and a low frequency of blood group B
[23], or defined as East and West European Roma, with
the former closely related to Indian populations [16].
Heterogeneity of Romani populations within the same
country has been suggested by the very small number of
studies addressing this issue [19,21,25,26].
In an attempt to summarise the existing data, we have
conducted a multilocus re-analysis of several marker sys-
tems using comparable studies of the Roma in different
European countries [11,22,23,24,26,27], Europeans
[28–33] and north Indian populations [34–36]. The
comparisons (Figure 2, Table 1) provide a general indica-
tion that most of the Roma are genetically closer to Indi-
ans than to European populations, hardly surprising in
view of the linguistic theories on the Indian origins of theBMC Medical Genetics (2001) 2:5 http://www.biomedcentral.com/1471-2350/2/5
Figure 2
Multilocus comparison between Romani populations from different European countries, autochthonous Euro-
pean  populations  and  populations from north  India  The polymorphic systems  included  in  the analysis  comprised
A1A2BO, MN, haptoglobin and Rh (CDE), with a total of 11 independent alleles. Information on these markers was available
for the Roma in Slovakia (n = 350) [26], Hungary (n = 507) [11], England (n = 109) [23], Slovenia (n = 350) [27], Sweden (n =
115) [24] and Wales (n = 84) [22], for non-Roma Europeans (n = 5169) and for two north Indian populations, Rajput (n = 175)
[34,35] and Punjabi (n = 140) [35,36]. Genetic distances between pairs of populations were computed by means of Reynold's
coancenstry coefficient [84] and displayed as a neighbour-joining tree [85]. The robustness of the branches in the tree was
assessed with a bootstrap approach [86]. The analysis was conducted using the PHYLIP 3.57c package [87].BMC Medical Genetics (2001) 2:5 http://www.biomedcentral.com/1471-2350/2/5
Roma proposed two centuries ago [1]. More importantly,
the analysis highlights the internal diversity of the Roma,
who appear to be genetically far more heterogeneous
than autochthonous European populations.
Genetic Disorders of the Roma
Diseases and mutations identified to-date
As a result of traditionally low socio-economic status and
limited access of the Roma to health care, their unique
genetic heritage has long escaped the attention of Euro-
pean medicine and is now being randomly "discovered".
To date, nine Mendelian disorders caused by private
"Romani" mutations have been described (Table 2).
The list includes three novel neurological disorders,
namely hereditary motor and sensory neuropathies type
Lom (HMSN-L) [37–39] and type Russe (HMSN-R)
[40], and the congenital cataracts facial dysmorphism
neuropathy syndrome (CCFDN) [41,42].
In addition, a number of previously known but rare dis-
orders have been identified and shown to be caused by
novel private mutations (Table 2). Examples include
limb-girdle muscular dystrophy type 2C (LGMD2C)
[43], galactokinase deficiency [44], primary congenital
glaucoma [45], and congenital myasthenia [46].
In view of the lack of systematic studies, the list cannot
be comprehensive and is likely to represent the biases
and interests of individual medical researchers working
in this field. Data in the literature, particularly from the
Spanish Collaborative Study of Congenital Malforma-
tions [47], point to the existence of a number of addition-
al rare single gene disorders, whose molecular basis is
still to be identified. These include hereditary idiopathic
torsion dystonia (ITD) [48], epidermolysis bullosa [49],
albinism [49], and some rare autosomal recessive mal-
formation syndromes, such as Bowen-Conradi, Jarcho-
Levin, Meckel, Smith-Lemli-Opitz, and Fraser [47,49].
A third group of Mendelian disorders includes common
conditions, where the mutation prevalent in the sur-
rounding or in global populations is likely to have been
introduced by admixture, for example cystic fibrosis and
delF508 [50], phenylketonuria and the R252W and
IVS10nt546 mutations [51,52], and medium chain acyl-
coenzyme A dehydrogenase (MCAD) deficiency and
G985 [53].
Molecular genetic findings
With the exception of phenylketonuria, Mendelian disor-
ders have been described as genetically homogeneous,
with a single mutation accounting for all affected indi-
viduals and related polymorphic haplotypes unambigu-
ously indicating a common origin and founder effect
[37–40,42–46].
At the same time, many studies emphasise the small size
of the conserved region of homozygosity and the diversi-
ty of disease haplotypes observed even within single af-
fected kindreds [37,40,42,44,54] (Figure 3). Haplotype
diversification, generated by numerous historical recom-
binations and marker mutations [39] as a consequence
of the old age [37,43] and high frequencies of disease-
causing mutations, has important implications for gene
mapping studies: (i) Homozygosity mapping, relying on
consanguinity in the affected families, is not applicable
in studies using the standard genetic maps and can result
in spuriously negative results [54]. (ii) The diversity of
historical recombinations becomes a powerful tool in the
subsequent refined genetic mapping and positional clon-
ing of disease genes [55,39].
Epidemiological data
Reported gene frequencies are high for both private and
"imported" mutations, and often exceed by an order of
magnitude those for global populations. For example,
galactokinase deficiency whose worldwide frequency is
1:150,000 to 1:1,000,000 [56,57] affects 1 in 5,000 Rom-
ani children [44]; autosomal dominant polycystic kidney
disease (ADPKD) has a global prevalence of 1:1000 indi-
viduals worldwide [58] and 1:40 among the Roma in
some parts of Hungary [17]; primary congenital glauco-
Table 1: Multi-locus reanalysis of previously published data on Eu-
ropean Roma
Populations Proportion of the variance ex-
plained by differences
between groups within 
groups
All Roma (n = 1287) versus 1.81 ±  1.45% 0.58 ±  0.29%
non-Roma Europeans
(n = 5169)
Roma (n = 1287) versus 0.36 ±  0.69% 2.8 ±  0.39%
North Indians (n = 315)
Between Romani 3.47 ±  0.46%
populations (n = 1287) in
Europe
Between European 0.19 ±  0.12%
Populations (n = 5169)
The populations and references included in the comparison are as in-
dicated in figure 2. Genetic variance was apportioned between and 
within populations and between and within groups of populations by 
means of the Analysis of Molecular Variance [88], as implemented in 
the Arlequin 1.1 package [89].BMC Medical Genetics (2001) 2:5 http://www.biomedcentral.com/1471-2350/2/5
ma ranges between 1:5,000 and 1:22,000 worldwide
[59,60] and about 1:400 among the Roma in Central Slo-
vakia [61,62].
Carrier rates for a number of disorders have been esti-
mated to be in the 5 to 20% range (Table 3).
Although incomplete, the available data already lead to
some practical conclusions: (i) What may appear to be a
novel disorder confined to a single family, could in fact
be an indication of a common problem affecting large
numbers of individuals. Research should therefore ex-
tend beyond case descriptions and aim at more compre-
hensive epidemiological information. (ii) The emphasis
on consanguinity in affected families displaces the focus
from an obvious need for public health intervention to
patterns of personal behaviour. In the face of the report-
ed high gene frequencies, consanguinity is no more rele-
vant than it would be as a cause of beta-thalassemia in
Mediterranean countries. (iii) High gene frequencies
may result in the parallel segregation of phenotypically
similar but genetically distinct disorders within the same
kindred [40,42]. This clustering should be borne in mind
in diagnostic studies, where assumptions based on pedi-
gree structure should be avoided and independent clini-
cal and genetic assessment should be conducted in all
cases.
Figure 3
Genetic mapping of hereditary motor and sensory neuropathy type Russe (HMSN-R): findings in the region of
linkage on chromosome 10q23 This affected family originates from a closed endogamous Romani group where consanguin-
eous marriages are common. The linkage study was conducted using the ABI Prism Linkage Mapping Sets LMS and LMS version
2 (PE Biosystems), with an average intermarker distance of 10 cM. The ABI panel markers flanking the HMSN-R region (shown
in blue) presented with different alleles in the affected individuals. Haplotype heterozygosity, resulting from historical recombi-
nations and a recent cross-over event (individual R-11), extended into the 10 cM interval containing the gene and could have
resulted in exclusion of the region if homozygosity mapping had been used. In the set of affected families included in the original
study [40], the conserved region of homozygosity (red bars) was found to span only <500 kb. Courtesy of Dr. Tamara Rogers.BMC Medical Genetics (2001) 2:5 http://www.biomedcentral.com/1471-2350/2/5
Table 2: Mendelian disorders of the Roma caused by private founder mutations
Disorder OMIM* Inheritance Map Gene Mutation Ref.
Location
Primary congenital 231300 AR 2p21 CYP1B1 E387K 45,54
Glaucoma
Galactokinase 230200 AR 17q24 GK1 P28T 44
Deficiency
Polycystic kidney 173900 AD 4q21-q23 PKD2 R306X** 90
Disease
Hereditary motor and 601455 AR 8q24 NDRG1 R148X 37,39
Sensory neuropathy-Lom
Hereditary motor and 605285 AR 10q23 40
Sensory neuropathy-Russe
Congenital cataracts facial 604168 AR 18qter 42
dysmorphism neuropathy
Limb girdle muscular 253700 AR 13q12 SGCG C283Y 43,65,
dystrophy type 2C 91
Congenital myasthenia 254210 AR 17p13 CHRNE 1267delG 46
Glanzmann 273800 AR 17q21 ITGA2B IVS15DS, 64,92
Thrombasthenia G-A+1
* Using the OMIM numbers, detailed clinical information can be obtained at http://www3.ncbi.nlm.nih.gov/Omim/ ** The R306X mutation in PKD2 
has been identified in Romani families from Bulgaria. It has not been confirmed in the Hungarian ADPKD families, but appears pr obable because of 
a reported common migration history of all affected groups.
Table 3: Reported carrier rates for single gene disorders among the Roma
Disorder Country General High-risk Ref.
Roma groups
Primary congenital glaucoma Slovakia 5% *11% 45,54
Galactokinase Bulgaria 2% *4%-5% 44
Deficiency
Autosomal dominant polycystic Hungary 2.4% 17
kidney disease
Hereditary motor and sensory Bulgaria *2% *20% 37,39
neuropathy-Lom
Limb girdle muscular dystrophy **Bulgaria 2% 6% 93,66
type 2C
MCAD deficiency ***Spain *2.5%-10% 53
Phenylketonuria Czecho 6% 94
slovakia
Oculocutaneous albinism Spain 3.4% 49
Fraser syndrome Spain 2.7% 47
Epidermolysis bullosa Spain 2.4% 49
Most estimates are based on prevalence figures. *Carrier rates determined through direct mutation detection are indicated in re d. **The LGMD2C 
carrier rates for the general Romani population of Bulgaria are probably an overestimate since the screening was conducted in a  geographical region 
where the high risk groups are clustered. ***The screening for the G985 mutation in Spain, performed in Gypsy groups residing i n different parts of 
the country, revealed substantial differences between groups.BMC Medical Genetics (2001) 2:5 http://www.biomedcentral.com/1471-2350/2/5
Research into Mendelian disorders has provided ample
evidence of genetic stratification, with mutations occur-
ring at high frequencies in some Romani communities
and altogether absent in others, located in close geo-
graphic proximity. In some cases, such as Glanzmann
thrombasthenia [63,64], LGMD2C [65,66], galactoki-
nase deficiency [44], CCFDN [42] and HMSN-R [40], the
identity of the affected groups has been specified. Other
studies, for example of congenital glaucoma [61,62] and
ADPKD [17] provide only an indication of the area of res-
idence of the affected communities. In the few cases
where gene frequencies can be compared between high-
risk groups and the general Romani population of the
same country, substantial differences become apparent
(Table 3).
At the same time, founder mutations have spread with
the Romani diaspora and are shared by affected individ-
uals throughout Europe (Figure 4). International collab-
oration has already made a substantial contribution to
the study of disease phenotypes in large samples of ge-
netically homogeneous patients [46, 67–71] as well as to
the refined mapping of disease genes [55]. Such collabo-
ration will be essential for future research into new dis-
orders, founder mutations and factors modifying disease
severity, and for understanding the epidemiology of ge-
netic diseases of the Roma. The first steps to European
collaboration have been made, with the founding of the
Gypsy Genetic Heritage Consortium in 1997, and the
forthcoming ENMC workshop on neuromuscular disor-
ders in Gypsies.
Discussion
The pattern emerging from genetic research is that of a
conglomerate of founder populations which extend
across Europe but at the same time differ within individ-
ual countries, and whose demographic history, internal
structure and relationships are poorly understood. An
insight is provided by the social sciences.
The 18th century theory on the Indian origins of the
Roma [reviewed in 1], is based on the similarities be-
tween Romani and languages spoken in the Indian sub-
continent and is supported by genetic evidence. However
the lack of close relationship to any specific language or
dialect has left unresolved the question of the original
ethnic composition of the proto-Roma, with both single
[72,73] and diverse [74] origins proposed by linguists.
Translated into the language of genetics, this is a relevant
question related to the homogeneity or diversity of the
founding population.
Inferred from linguistic influences retained in all Roma-
ni dialects, the major migration routes pass through Per-
sia, Armenia, Greece and the Slavic-speaking parts of the
Balkans [1]. The first documents pointing to the arrival of
the Roma in the Balkans date from the 11th-12th century
[1,75]. By the 15th century, mention of their presence can
be found in historical records from all parts of Europe
[1,2].
Historical demographic data are limited, however tax
registries and census data give an approximate idea of
population size and rate of demographic growth through
the centuries (Table 4). A small size of the original popu-
lation is suggested by the fact that although most of the
migrants arriving in Europe in the 11th-12th century re-
mained within the limits of the Ottoman Empire [1,75],
the overall number of Roma in its Balkan provinces in
the 15th century was estimated at only 17,000.
During its subsequent history in Europe, this founder
population split into numerous socially divided and geo-
graphically dispersed endogamous groups, with histori-
cal records from different parts of the continent
consistently describing the travelling Gypsies as "a group
of 30 to 100 people led by an elder" [1,2]. These splits, a
possible compound product of the ancestral tradition of
the jatis of India, and the new social pressures in Europe
(e.g. Gypsy slavery in Romania [76] and repressive legis-
lation banning Gypsies from most western European
countries [1,2]), can be regarded as secondary bottle-
necks, reducing further the number of unrelated found-
ers in each group. The historical formation of the
present-day 8 million Romani population of Europe is
therefore the product of the complex initial migrations of
numerous small groups, superimposed on which are two
large waves of recent migrations from the Balkans into
Western Europe, in the 19th - early 20th century, after the
abolition of slavery in Rumania [1,2,76] and over the last
decade, after the political changes in Eastern Europe
[7,8].
The Group is still the primary building block of the social
organisation of the Roma [1,2]. Group identity and the
ensuing divisions and rules of endogamy are based on
tradition, customs and organs of self-rule, language and
dialects, trades, history of migrations, and religion. Indi-
vidual groups can be classified into major metagroups
[1,2,75]: the Roma of East European extraction; the Sinti
in Germany and Manouches in France and Catalonia; the
Kaló in Spain, Ciganos in Portugal and Gitans of south-
ern France; and the Romanichals of Britain [1]. The
greatest diversity is found in the Balkans, where numer-
ous groups with well defined social boundaries exist. The
700-800,000 Roma in Bulgaria belong to three meta-
groups, comprising a large number of smaller groups
[75].BMC Medical Genetics (2001) 2:5 http://www.biomedcentral.com/1471-2350/2/5
Figure 4
Distribution of reported founder mutations in Europe The figure is based on available information referring to the fol-
lowing disorders: • Infantile cataracts due to galactokinase deficiency in Bulgaria [44], Austria [95], Switzerland [96], Italy [97],
Hungary and Spain [our unpublished findings]. • Hereditary motor and sensory neuropathy - Lom in Bulgaria [37,38], Italy [68],
Slovenia [69], Germany [70], Spain [71], France and Romania [55] and Hungary [our unpublished findings]. • Congenital cata-
racts facial dysmorphism neuropathy syndrome in Bulgaria [41,42], Romania, Hungary and the United States [our unpublished
findings]. • Limb girdle muscular dystrophy type 2C in France, Spain, Italy, Germany [43], Portugal [91] and Bulgaria [65,66,93].
• Congenital myasthenia in Serbia, Macedonia, Greece, Bohemia and Germany [46]. • Hereditary motor and sensory neuropa-
thy - Russe in Bulgaria [40], Romania and Spain [our unpublished findings]. The existing data are the product of ad-hoc collabo-
rative studies and are not likely to represent the true spread of Romani founder mutations. The distribution of LGMD2C in
Western Europe and in Bulgaria leads to the prediction that the disorder occurs and awaits detection along the entire Euro-
pean migration route, spanning the Balkans and Central Europe. Filling the gaps in the map will be particularly useful in the case
of treatable disorders which are strong candidates for newborn screening, such as galactokinase deficiency and congenital
myasthenia.BMC Medical Genetics (2001) 2:5 http://www.biomedcentral.com/1471-2350/2/5
Linguistics, history and cultural anthropology suggest
two major, equally plausible historical scenarios that
could lead to a "jigsaw puzzle" of founder populations: (i)
a genetically substructured ancestral population, where
the old social traditions of strict endogamy have been re-
tained and subsequent splits of the comprising groups
have enhanced the original genetic differences; (ii) a
small homogeneous ancestral population spawning nu-
merous subgroups where strong drift effects have result-
ed in substantial genetic divergence. Genetic research
has indeed faced the "jigsaw puzzle" and has thus far
been unable to resolve it. The genetic data provide evi-
dence of population stratification, however a closer ex-
amination is precluded by the random cross-section
sampling design of most population genetic studies,
where the traditional social organisation and self-identi-
ty of the Roma have been ignored and subjects classified
on the basis of the political boundaries of Europe. The re-
lationship between social organisation and genetic struc-
ture does not appear to be straightforward and is still to
be addressed in population genetic research based on the
long standing identity of Gypsy groups. The issue is of
relevance to public health policies and the targeted pre-
vention of mendelian disorders, as well as to future stud-
ies of genetically complex disorders.
The existing information on single gene disorders is cer-
tainly not exclusive to the Roma. The phenomenon of
clustering of rare disorders and private founder muta-
tions has been studied in detail in well characterised
founder populations, such as the Jews [77,78], Finns
[79,80] and French Canadians [81]. Unlike the above ex-
amples however, genetic studies of the Roma have failed
to take the immediate benefits of research back to the in-
dividuals and families that have been the object of re-
search. Yet by now it should be obvious that genetics has
an important role to play in improving the quality of
health care for the Roma. Treatable disorders such as ga-
lactokinase and MCAD deficiency, with an expected inci-
dence of affected births in the range of 1:1,000 to
1:5,000, meet the standard criteria for newborn screen-
ing more than does phenylketonuria, with its average in-
cidence of 1:10,000. Adding the simple, sensitive and
specific mutation tests to existing newborn screening
programs would be technically simple and highly effi-
cient due to the homogeneous genetic basis of the disor-
ders.
Carrier testing should be made available to Romani com-
munities at high risk for severe untreatable disorders. In-
formation on the identity of affected Romani
populations is important for public health intervention
since it would allow the planning and facilitate the imple-
mentation of targeted prevention programs, especially in
the Eastern European countries where economic re-
sources are limited. The importance of the educational
component of such programs has already been demon-
strated by the highly successful prevention of Tay-Sachs
disease among Ashkenazi Jews [82] and the failure of
sickle-cell screening among Afro-Americans [83]. This
component would be particularly important for a popu-
lation like the Roma, which has been subject to racism
and persecution throughout its co-existence with Euro-
pean societies.
The attention of geneticists is increasingly attracted by
genetically isolated populations in the third world. In
terms of living standards and the major health indica-
tors, the Roma are much closer to the developing world
than to their European neighbours [3]. This forgotten
people of Europe can be regarded as a test case for the ca-
pacity of genetics to provide better health.
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